PIN4 COST-BENEFIT ANALYSIS OF OSELTAMIVIR VERSUS NO ANTIVIRAL TREATMENT FROM THE EMPLOYER PERSPECTIVE-THE ROCHE BRAZIL CASE

Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65511-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)65511-8/fulltext
Title : PIN4 COST-BENEFIT ANALYSIS OF OSELTAMIVIR VERSUS NO ANTIVIRAL TREATMENT FROM THE EMPLOYER PERSPECTIVE-THE ROCHE BRAZIL CASE
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65511-8&doi=10.1016/S1098-3015(10)65511-8
First page :
Section Title :
Open access? : No
Section Order : 669
Categories :
Tags :
Regions :
ViH Article Tags :